Cargando…

Association between family history, mutation locations, and prevalence of BRCA1 or 2 mutations in ovarian cancer patients

We investigated the prevalence of germline BRCA mutations in a population‐based cohort of Austrian women diagnosed with ovarian cancer and its association with family history of cancer. We prospectively collected family pedigrees of 443 Austrian ovarian cancer patients who had been tested for the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singer, Christian F., Tan, Yen Y., Muhr, Daniela, Rappaport, Christine, Gschwantler‐Kaulich, Daphne, Grimm, Christoph, Polterauer, Stephan, Pfeiler, Georg, Berger, Andreas, Tea, Muy‐Kheng M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488144/ https://www.ncbi.nlm.nih.gov/pubmed/30821131 http://dx.doi.org/10.1002/cam4.2000

Ejemplares similares

Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriers
por: Rieder, Viktoria, et al.
Publicado: (2015)

Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers
por: Gschwantler-Kaulich, Daphne, et al.
Publicado: (2017)

Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers
por: Gschwantler-Kaulich, Daphne, et al.
Publicado: (2018)

Outcomes and risk of subsequent breast events in breast‐conserving surgery patients with BRCA1 and BRCA2 mutation
por: Ye, Fugui, et al.
Publicado: (2020)

CA125 Levels in BRCA mutation carriers – a retrospective single center cohort study
por: Gebhart, P, et al.
Publicado: (2023)

BRCA1/2 Mutations Appear Embryo-Lethal Unless Rescued by Low (CGG n<26) FMR1 Sub-Genotypes: Explanation for the “BRCA Paradox”?
por: Weghofer, Andrea, et al.
Publicado: (2012)

Cancer Spectrum, Family History of Cancer and Overall Survival in Men with Germline BRCA1 or BRCA2 Mutations
por: Reichl, Florian, et al.
Publicado: (2021)

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer
por: Bekos, Christine, et al.
Publicado: (2021)

Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect”
por: Staudigl, Christine, et al.
Publicado: (2016)

Association between targeted somatic mutation (TSM) signatures and HGS‐OvCa progression
por: Lindley, Robyn A., et al.
Publicado: (2016)

Analysis of risk factors and gene mutation characteristics of different metastatic sites of lung cancer
por: Wang, Bin, et al.
Publicado: (2021)

Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool
por: Tea, Muy-Kheng M., et al.
Publicado: (2018)

HER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK
por: Gschwantler-Kaulich, Daphne, et al.
Publicado: (2016)

Nutlin‐3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation
por: Hui, Wen, et al.
Publicado: (2018)

Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population‐based study
por: Jones, Tarsha, et al.
Publicado: (2017)

Hepatitis B virus mutations, expression quantitative trait loci for PTPN12, and their interactions in hepatocellular carcinoma
por: Song, Ci, et al.
Publicado: (2016)

Early‐onset triple‐negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations
por: Liu, Qian, et al.
Publicado: (2019)

Race, tumor location, and disease progression among low‐risk prostate cancer patients
por: Mygatt, Justin G., et al.
Publicado: (2020)

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
por: Li, Jingmei, et al.
Publicado: (2018)

Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients
por: Aasebø, Kristine Ø., et al.
Publicado: (2019)

Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer
por: Danzinger, Sabine, et al.
Publicado: (2019)

Family history of breast cancer and its association with disease severity and mortality
por: Melvin, Jennifer C., et al.
Publicado: (2016)

Assessment of associations between clinical and immune microenvironmental factors and tumor mutation burden in resected nonsmall cell lung cancer by applying machine learning to whole‐slide images
por: Ono, Akira, et al.
Publicado: (2020)

Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria
por: Deutschmann, Christine, et al.
Publicado: (2022)

A population study of screening history and diagnostic outcomes of women with invasive cervical cancer
por: Benard, Vicki B., et al.
Publicado: (2021)

Gender differences in self‐reported family history of cancer: A review and secondary data analysis
por: Sieverding, Monika, et al.
Publicado: (2020)

History of chickenpox in glioma risk: a report from the glioma international case–control study (GICC)
por: Amirian, E. Susan, et al.
Publicado: (2016)

Association of family history and survival in patients with colorectal cancer: a pooled analysis of eight epidemiologic studies
por: Chong, Dawn Q., et al.
Publicado: (2018)

Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database
por: Lupo, Philip J, et al.
Publicado: (2015)

Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
por: Campacci, Natalia, et al.
Publicado: (2017)

Letter to the Editor Re: A population study of screening history and diagnostic outcomes of women with invasive cervical cancer
por: Castle, Philip E.
Publicado: (2021)

Cadherin-11 expression is upregulated in invasive human breast cancer
por: Pohlodek, Kamil, et al.
Publicado: (2016)

Prolonged recombinant pregnancy hormone use in BRCA1 and BRCA2 mutation carriers
por: Depypere, Herman, et al.
Publicado: (2021)

Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older—A national cohort study
por: Hammer, Anne, et al.
Publicado: (2019)

Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta‐analysis of observational studies
por: Schwingshackl, Lukas, et al.
Publicado: (2015)

Efficacy and safety of osimertinib in treating EGFR‐mutated advanced NSCLC: A meta‐analysis
por: Yi, Lilan, et al.
Publicado: (2019)

The prevalence of current smokers and alcohol drinkers among cancer survivors and subjects with no history of cancer among participants in a community‐based cardiometabolic screening program in Miyagi prefecture, Japan: a comparison with nationally representative surveys in other countries
por: Nishimoto, Yuka, et al.
Publicado: (2021)

Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
por: Wen, Wei Xiong, et al.
Publicado: (2018)

Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer"
por: Deutschmann, Christine, et al.
Publicado: (2023)

Incidence and long‐term outcome of postradiotherapy moyamoya syndrome in pediatric patients with primary brain tumors: a single institute experience in Taiwan
por: Wu, Yuan‐Hung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lf1f2je0tviuvkc763eb6k7sj9